PCI and its successful efforts to support Penn’s research and innovation over the past decade were highlighted in the Summer issue of the Penn Gazette. Founded in 2014, PCI has consolidated technology translation and commercialization efforts across the university to create strategic partnerships and move groundbreaking ideas from academia to industry. This significant boost to Penn’s entrepreneurial and innovation capabilities resulted in record-breaking revenues and has now established the university as a clear leader in innovation.
John Swartley, PhD, MBA, Chief Innovation Officer, and Ben Dibling, PhD, Associate Vice Provost for Research and Managing Director of PCI, both share their insights with the Penn Gazette about the history and future of innovation at Penn.
The article also highlights how PCI provided crucial support in navigating the commercialization process for world-renowned Penn-invented technologies, including CAR T cell therapy and the mRNA technology that made the life-saving COVID-19 vaccines possible. Read the full article here.